Lei Xi Selected Research

Inosine

6/2015	Inosine and hypoxanthine as novel biomarkers for cardiac ischemia: from bench to point-of-care.
1/2011	A rapid and simple chemiluminescence method for screening levels of inosine and hypoxanthine in non-traumatic chest pain patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Xi Research Topics

Disease

40	Neoplasms (Cancer) 01/2023 - 09/2010
23	Ischemia 03/2023 - 07/2002
14	Hypoxia (Hypoxemia) 05/2024 - 12/2004
13	Reperfusion Injury 02/2014 - 02/2004
12	Infarction (Infarctions) 04/2022 - 07/2002
11	Myocardial Infarction 03/2023 - 01/2006
10	Breast Neoplasms (Breast Cancer) 07/2023 - 05/2013
10	Cardiotoxicity 01/2023 - 09/2010
9	Erectile Dysfunction 03/2023 - 04/2003
7	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 09/2013
7	Necrosis 11/2018 - 04/2005
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2017
6	Myocardial Ischemia (Ischemic Heart Diseases) 06/2015 - 10/2008
5	Cardiomyopathies (Cardiomyopathy) 05/2012 - 09/2010
4	Heart Failure 01/2023 - 01/2009
4	Pulmonary Arterial Hypertension 01/2023 - 04/2005
4	Inflammation (Inflammations) 12/2022 - 09/2018
4	Glaucoma 01/2020 - 01/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2011
3	Cognitive Dysfunction 05/2024 - 10/2019
3	Hyperoxia 05/2024 - 08/2015
3	Cardiomegaly (Heart Hypertrophy) 01/2023 - 01/2011
3	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2020
3	Body Weight (Weight, Body) 01/2023 - 02/2014
3	Lung Neoplasms (Lung Cancer) 11/2021 - 09/2010
3	Fibrosis (Cirrhosis) 09/2020 - 10/2014
3	Atrial Fibrillation 01/2014 - 01/2011
3	Pulmonary Hypertension 01/2011 - 02/2004
2	Glioma (Gliomas) 04/2024 - 01/2012
2	COVID-19 03/2023 - 12/2020
2	Hyperglycemia 03/2023 - 01/2017
2	Infections 03/2023 - 01/2021
2	Insulin Resistance 03/2023 - 01/2017
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2023 - 03/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 04/2016
2	Astigmatism 02/2020 - 05/2018
2	Myopia 02/2020 - 08/2018
2	Hypothermia 01/2020 - 12/2008
2	Prediabetic State (Prediabetes) 03/2019 - 01/2017
2	Neoplasm Metastasis (Metastasis) 01/2019 - 04/2016
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 02/2014

Drug/Important Bio-Agent (IBA)

16	Sildenafil Citrate (Viagra)FDA Link 03/2023 - 04/2003
12	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 03/2023 - 04/2005
10	Phosphodiesterase 5 InhibitorsIBA 03/2023 - 04/2005
10	Tadalafil (Cialis)FDA Link 03/2023 - 02/2004
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2011
8	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2011
7	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 09/2010
6	NitratesIBA 05/2020 - 05/2011
5	Vardenafil Dihydrochloride (Levitra)FDA Link 03/2023 - 02/2004
4	Insulin (Novolin)FDA Link 03/2023 - 02/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2022 - 10/2006
4	Therapeutic UsesIBA 03/2022 - 01/2011
4	Hemoglobins (Hemoglobin)IBA 01/2021 - 08/2015
4	PolymersIBA 01/2021 - 12/2019
4	Glucose (Dextrose)FDA LinkGeneric 05/2020 - 02/2014
4	Small Interfering RNA (siRNA)IBA 01/2017 - 10/2005
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2023 - 01/2017
3	Blood Glucose (Blood Sugar)IBA 03/2023 - 01/2017
3	Antimalarials (Antimalarial Agents)IBA 03/2023 - 01/2017
3	Retinaldehyde (Retinal)IBA 07/2022 - 01/2020
3	pigment epithelium-derived factorIBA 07/2022 - 01/2020
3	Contrast MediaIBA 01/2021 - 03/2013
3	LigandsIBA 01/2021 - 01/2006
3	HypoxanthineIBA 06/2020 - 01/2011
3	NitritesIBA 05/2020 - 05/2011
3	Sirtuin 1IBA 12/2019 - 01/2014
3	Messenger RNA (mRNA)IBA 03/2019 - 06/2012
3	InterleukinsIBA 01/2019 - 01/2013
3	Adenosine Triphosphate (ATP)IBA 01/2017 - 04/2003
3	OsteoprotegerinIBA 01/2014 - 01/2011
3	RANK LigandIBA 01/2014 - 01/2011
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2010 - 07/2002
3	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2008 - 02/2004
2	Progesterone Receptors (Progesterone Receptor)IBA 07/2023 - 05/2014
2	EnzymesIBA 03/2023 - 09/2013
2	LipidsIBA 03/2023 - 05/2020
2	AndrogensIBA 01/2023 - 01/2020
2	Bevacizumab (Avastin)FDA Link 07/2022 - 05/2014
2	cytotropic heterogeneous molecular lipid (CHML)IBA 01/2022 - 11/2021
2	Long Noncoding RNAIBA 12/2021 - 04/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 09/2010
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021 - 09/2020
2	Antiviral Agents (Antivirals)IBA 12/2020 - 09/2018
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2020 - 08/2018
2	TroponinIBA 06/2020 - 06/2015
2	Natriuretic PeptidesIBA 06/2020 - 08/2018
2	p38 Mitogen-Activated Protein KinasesIBA 03/2019 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 12/2017 - 08/2017
2	ErbB Receptors (EGF Receptor)IBA 12/2017 - 08/2017
2	Pentylenetetrazole (Metrazol)IBA 11/2017 - 08/2015
2	visnaginIBA 02/2016 - 01/2016
2	AnthracyclinesIBA 01/2016 - 05/2011
2	Inosine FDA Link 06/2015 - 01/2011

Therapy/Procedure

14	Therapeutics 03/2023 - 05/2012
9	Drug Therapy (Chemotherapy) 07/2023 - 05/2012
4	Lasers (Laser) 01/2023 - 01/2021
3	Precision Medicine 01/2023 - 09/2020
3	Photorefractive Keratectomy 02/2020 - 05/2018
2	Radiotherapy 01/2022 - 09/2010